Company Filing History:
Years Active: 1999-2007
Title: Jacqueline De Bruyn: Innovator in Recombinant Polypeptides
Introduction
Jacqueline De Bruyn is a prominent inventor based in Beersel, Belgium. She has made significant contributions to the field of biotechnology, particularly in the development of recombinant polypeptides and peptides. With a total of 6 patents to her name, her work has the potential to impact the diagnosis and treatment of tuberculosis.
Latest Patents
Among her latest inventions, Jacqueline has developed polypeptides that contain specific amino acid sequences crucial for tuberculosis diagnostics. These polypeptides can also serve as active components in vaccine preparations against tuberculosis. Her innovative approach addresses a critical need in public health and showcases her expertise in biochemistry.
Career Highlights
Jacqueline De Bruyn is associated with N.V. Innogenetics S.A., a company known for its advancements in molecular diagnostics and therapeutic solutions. Her role at the company has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to biotechnology.
Collaborations
Some of her notable coworkers include Jean Content and Lucas De Wit. Their collective efforts in research and development have fostered an environment of innovation and creativity within their projects.
Conclusion
Jacqueline De Bruyn's work in recombinant polypeptides represents a significant advancement in the fight against tuberculosis. Her dedication to innovation and collaboration continues to inspire future developments in biotechnology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.